Fundz

Facible Bio Diagnostics, Inc. reported raising $2.79 Million in an initial SEC Form D filing, from an offering of $2.79 Million

PRIVATEMay 02, 2022

Amount Raised

$2.79 Million

$2.79 Million sold, per SEC Form D (first sale May 2, 2022)

Round Type

Seed

MeridianBiotechnology

Quick answer

Facible BioDiagnostics, Inc. raised $2.79 Million in a Seed round, dated May 2, 2022. Facible BioDiagnostics, Inc. is based in Meridian, Idaho, United States.

How much did Facible BioDiagnostics, Inc. raise?
Facible BioDiagnostics, Inc. raised $2.79 Million in a Seed round on May 2, 2022.
What does Facible BioDiagnostics, Inc. do?
Facible’s technology enables the development of rapid point-of-use diagnostic tests that require minimal equipment and training.
Where is Facible BioDiagnostics, Inc. based and how big is it?
Facible BioDiagnostics, Inc. is based in Meridian, Idaho, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Facible BioDiagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Kindeva Drug Delivery raised $5M on June 16, 2022.
  • Virica Biotech Inc. raised $500K (Seed) on June 16, 2022.
  • Artio Medical, Inc. raised $28M (Series A) on June 16, 2022.
  • Swing Therapeutics raised $10M (Series A) on June 16, 2022.
  • Akero Therapeutics raised an undisclosed amount (Funding Round) on June 16, 2022.
  • Voltron Therapeutics, Inc. raised $300K (Seed) on June 16, 2022.

Who to call at Facible BioDiagnostics, Inc., and when

A new round usually means Facible BioDiagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Facible BioDiagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Facible BioDiagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Facible BioDiagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Facible BioDiagnostics, Inc.

Location

366 SW 5TH AVE

Meridian, Idaho, United States

About

Facible’s technology enables the development of rapid point-of-use diagnostic tests that require minimal equipment and training.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Facible BioDiagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Facible BioDiagnostics, Inc.'s next move

See what Strategic adds

Facible BioDiagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.